Amundi - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 178 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.3%.

Quarter-by-quarter ownership
Amundi ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$81,643
-12.1%
4,6520.0%0.00%
Q2 2023$92,854
+3.3%
4,652
-14.2%
0.00%
Q1 2023$89,901
-19.0%
5,4190.0%0.00%
Q4 2022$110,927
+65.6%
5,419
+39.5%
0.00%
Q3 2022$67,000
-5.6%
3,885
+1.3%
0.00%
Q4 2021$71,000
-38.3%
3,8360.0%0.00%
Q3 2021$115,000
-32.4%
3,8360.0%0.00%
Q2 2021$170,0003,8360.00%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
M28 Capital Management LP 715,880$9,851,00011.04%
RTW INVESTMENTS, LP 15,802,802$217,447,0005.62%
Amitell Capital Pte Ltd 97,331$1,339,0003.05%
Prosight Management, LP 276,802$3,809,0003.00%
TANG CAPITAL MANAGEMENT LLC 1,265,900$17,419,0002.64%
Affinity Asset Advisors, LLC 250,466$3,446,0001.45%
COWEN AND COMPANY, LLC 1,000,000$13,760,0001.33%
Boxer Capital, LLC 1,466,051$20,173,0001.28%
Cormorant Asset Management, LP 868,550$11,951,0000.90%
MAVERICK CAPITAL LTD 2,532,366$34,845,0000.86%
View complete list of ROCKET PHARMACEUTICALS INC shareholders